Premium
Does the orphan medicinal product regulation assist or hinder access to innovative haemophilia treatment in Europe ?
Author(s) -
O'Mahony B.,
Peyvandi F.,
Bok A.
Publication year - 2014
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/hae.12462
Subject(s) - haemophilia , medicine , haemophilia b , orphan drug , haemophilia a , clotting factor , european union , authorization , pediatrics , international trade , bioinformatics , business , biology , computer security , computer science
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom